Cargando…
Tocilizumab: A Review of Its Safety and Efficacy in Rheumatoid Arthritis
Recent years have seen many exciting developments in the treatment of rheumatoid arthritis. Tocilizumab (TCZ) is a monoclonal antibody which inhibits the interleukin-6 receptor. After initial studies in Japan, it has been extensively studied in five multicentre clinical trials. This report summarise...
| Autores principales: | , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Libertas Academica
2010
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3018893/ https://www.ncbi.nlm.nih.gov/pubmed/21234291 http://dx.doi.org/10.4137/CMAMD.S4864 |